Does RISEDRONATE Cause Basal cell carcinoma? 7 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Basal cell carcinoma have been filed in association with RISEDRONATE (Risedronate Sodium). This represents 0.1% of all adverse event reports for RISEDRONATE.
7
Reports of Basal cell carcinoma with RISEDRONATE
0.1%
of all RISEDRONATE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Basal cell carcinoma From RISEDRONATE?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISEDRONATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RISEDRONATE Cause?
Drug hypersensitivity (1,124)
Asthma (1,087)
Pain (973)
Vomiting (971)
Drug ineffective (919)
Dyspnoea (898)
Pneumonia (807)
Wheezing (772)
Oedema (708)
Malaise (668)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which RISEDRONATE Alternatives Have Lower Basal cell carcinoma Risk?
RISEDRONATE vs RISEDRONIC ACID
RISEDRONATE vs RISPERDAL
RISEDRONATE vs RISPERDAL CONSTA
RISEDRONATE vs RISPERIDONE
RISEDRONATE vs RITALIN